{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:34:02Z","timestamp":1792794842825,"version":"4.5.0"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2021,2,16]],"date-time":"2021-02-16T00:00:00Z","timestamp":1613433600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Canadian Institutes of Health Research Canada Research Chair","id":[{"id":"https:\/\/ror.org\/01gavpb45","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Health Psychology at York University"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,6,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate the feasibility and safety of hyperbaric oxygen therapy (HBOT) in patients with fibromyalgia (FM).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>A cohort study with a delayed treatment arm used as a comparator.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Hyperbaric Medicine Unit, Toronto General Hospital, Ontario, Canada.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Subjects<\/jats:title>\n                    <jats:p>Eighteen patients diagnosed with FM according to the American College of Rheumatology and a score \u226560 on the Revised Fibromyalgia Impact Questionnaire.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Participants were randomized to receive immediate HBOT intervention (n\u2009=\u20099) or HBOT after a 12-week waiting period (n\u2009=\u20099). HBOT was delivered at 100% oxygen at 2.0 atmospheres per session, 5\u2009days per week, for 8\u2009weeks. Safety was evaluated by the frequency and severity of adverse effects reported by patients. Feasibility was assessed by recruitment, retention, and HBOT compliance rates. Both groups were assessed at baseline, after HBOT intervention, and at 3 months\u2019 follow-up. Validated assessment tools were used to evaluate pain, psychological variables, fatigue, and sleep quality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 17 patients completed the study. One patient withdrew after randomization. HBOT-related adverse events included mild middle-ear barotrauma in three patients and new-onset myopia in four patients. The efficacy of HBOT was evident in most of the outcomes in both groups. This improvement was sustained at 3-month follow-up assessment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>HBOT appears to be feasible and safe for individuals with FM. It is also associated with improved global functioning, reduced symptoms of anxiety and depression, and improved quality of sleep that was sustained at 3-month follow-up assessment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/pm\/pnaa416","type":"journal-article","created":{"date-parts":[[2020,10,31]],"date-time":"2020-10-31T16:09:59Z","timestamp":1604160599000},"page":"1324-1332","source":"Crossref","is-referenced-by-count":24,"title":["Evaluation of a Hyperbaric Oxygen Therapy Intervention in Individuals with Fibromyalgia"],"prefix":"10.1093","volume":"22","author":[{"given":"K","family":"Curtis","sequence":"first","affiliation":[{"name":"Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Katz","sequence":"additional","affiliation":[{"name":"Department of Psychology, York University, Toronto, Ontario, Canada"},{"name":"Department of Anesthesia and Pain Management, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Djaiani","sequence":"additional","affiliation":[{"name":"Hyperbaric Medicine Unit, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"O\u2019Leary","sequence":"additional","affiliation":[{"name":"Department of Anesthesia and Pain Management, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Uehling","sequence":"additional","affiliation":[{"name":"Hyperbaric Medicine Unit, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Carroll","sequence":"additional","affiliation":[{"name":"Department of Anesthesia and Pain Management, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Santa Mina","sequence":"additional","affiliation":[{"name":"Department of Anesthesia and Pain Management, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada"},{"name":"Faculty of Kinesiology and Physical Education, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Clarke","sequence":"additional","affiliation":[{"name":"Department of Anesthesia and Pain Management, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada"},{"name":"Hyperbaric Medicine Unit, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Gofeld","sequence":"additional","affiliation":[{"name":"Silver Medical Group, North York, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Katznelson","sequence":"additional","affiliation":[{"name":"Department of Anesthesia and Pain Management, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada"},{"name":"Hyperbaric Medicine Unit, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,2,16]]},"reference":[{"issue":"1","key":"2021060807584180400_pnaa416-B1","first-page":"9","article-title":"The epidemiology of self-reported fibromyalgia in Canada","volume":"27","author":"McNally","year":"2006","journal-title":"Chronic Dise Canada"},{"issue":"9","key":"2021060807584180400_pnaa416-B2","doi-asserted-by":"crossref","first-page":"907","DOI":"10.4065\/mcp.2011.0206","article-title":"The science of fibromyalgia","volume":"86","author":"Clauw","year":"2011","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"2021060807584180400_pnaa416-B3","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/1529-0131(200002)13:1<42::AID-ART7>3.0.CO;2-R","article-title":"Quality of life issues for fibromyalgia patients","volume":"13","author":"Bernard","year":"2000","journal-title":"Arthritis Care Res"},{"issue":"5","key":"2021060807584180400_pnaa416-B4","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/acr.20140","article-title":"The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity","volume":"62","author":"Wolfe","year":"2010","journal-title":"Arthritis Care Res"},{"issue":"3","key":"2021060807584180400_pnaa416-B5","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1155\/2013\/918216","article-title":"2012 Canadian Guidelines for the diagnosis and management of fibromyalgia syndrome: Executive summary","volume":"18","author":"Fitzcharles","year":"2013","journal-title":"Pain Res Manag"},{"issue":"2","key":"2021060807584180400_pnaa416-B6","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00296-009-1126-x","article-title":"Effect of aerobic exercise training on oxygen uptake and kinetics in patients with fibromyalgia","volume":"30","author":"Dinler","year":"2009","journal-title":"Rheumatol Int"},{"issue":"3","key":"2021060807584180400_pnaa416-B7","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.mehy.2005.10.037","article-title":"The pain of fibromyalgia syndrome is due to muscle hypoperfusion induced by regional vasomotor dysregulation","volume":"69","author":"Katz","year":"2007","journal-title":"Med Hypotheses"},{"issue":"2","key":"2021060807584180400_pnaa416-B8","first-page":"353","article-title":"Peak oxygen uptake and ventilatory anaerobic threshold in fibromyalgia","volume":"29","author":"Valim","year":"2002","journal-title":"J Rheumatol"},{"issue":"5","key":"2021060807584180400_pnaa416-B9","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3109\/03009742.2013.767372","article-title":"Metabolic rate, cardiac response, and aerobic capacity in fibromyalgia: A case-control study","volume":"42","author":"Bardal","year":"2013","journal-title":"Scand J Rheumatol"},{"issue":"6","key":"2021060807584180400_pnaa416-B10","doi-asserted-by":"crossref","first-page":"R236","DOI":"10.1186\/ar4079","article-title":"Noninvasive optical characterization of muscle blood flow, oxygenation, and metabolism in women with fibromyalgia","volume":"14","author":"Shang","year":"2012","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"2021060807584180400_pnaa416-B11","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1113\/jphysiol.1983.sp014857","article-title":"Responses in muscle afferent fibres of slow conduction velocity to contractions and ischaemia in the cat","volume":"342","author":"Mense","year":"1983","journal-title":"J Physiol"},{"issue":"3","key":"2021060807584180400_pnaa416-B12","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/1529-0131(199803)41:3<406::AID-ART5>3.0.CO;2-L","article-title":"Use of P-31 magnetic resonance spectroscopy to detect metabolic abnormalities in muscles of patients with fibromyalgia","volume":"41","author":"Park","year":"1998","journal-title":"Arthritis Rheum"},{"issue":"5","key":"2021060807584180400_pnaa416-B13","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1177\/03635465990270050901","article-title":"Effects of hyperbaric oxygen on a human model of injury","volume":"27","author":"Staples","year":"1999","journal-title":"Am J Sports Med"},{"key":"2021060807584180400_pnaa416-B14","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.biopha.2018.10.157","article-title":"Hyperbaric oxygen and aerobic exercise in the long-term treatment of fibromyalgia: A narrative review","volume":"109","author":"El-Shewy","year":"2019","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"2021060807584180400_pnaa416-B15","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1177\/147323000403200305","article-title":"A new treatment modality for fibromyalgia syndrome: Hyperbaric oxygen therapy","volume":"32","author":"Yildiz","year":"2004","journal-title":"J Int Med Res"},{"issue":"5","key":"2021060807584180400_pnaa416-B16","doi-asserted-by":"crossref","first-page":"e0127012","DOI":"10.1371\/journal.pone.0127012","article-title":"Hyperbaric oxygen therapy can diminish fibromyalgia syndrome\u2014prospective clinical trial","volume":"10","author":"Efrati","year":"2015","journal-title":"PLoS One"},{"key":"2021060807584180400_pnaa416-B17","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.3389\/fpsyg.2018.02495","article-title":"Hyperbaric oxygen therapy can induce neuroplasticity and significant clinical improvement in patients suffering from fibromyalgia with a history of childhood sexual abuse\u2014randomized controlled trial","volume":"9","author":"Hadanny","year":"2018","journal-title":"Front Psychol"},{"issue":"4","key":"2021060807584180400_pnaa416-B18","doi-asserted-by":"crossref","first-page":"R120","DOI":"10.1186\/ar2783","article-title":"The Revised Fibromyalgia Impact Questionnaire (FIQR): validation and psychometric properties","volume":"11","author":"Bennett","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"2021060807584180400_pnaa416-B19","first-page":"653714","article-title":"A comprehensive evaluation of standardized assessment tools in the diagnosis of fibromyalgia and in the assessment of fibromyalgia severity","volume":"2012","author":"Boomershine","year":"2012","journal-title":"Pain Res Treat"},{"issue":"6","key":"2021060807584180400_pnaa416-B20","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatrica Scand"},{"issue":"10","key":"2021060807584180400_pnaa416-B21","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1001\/archneur.1989.00520460115022","article-title":"The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus","volume":"46","author":"Krupp","year":"1989","journal-title":"Arch Neurol"},{"issue":"4","key":"2021060807584180400_pnaa416-B22","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0895-4356(88)90138-2","article-title":"A scale for the estimation of sleep problems in clinical research","volume":"41","author":"Jenkins","year":"1988","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"2021060807584180400_pnaa416-B23","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.pain.2010.02.018","article-title":"Research design considerations for confirmatory chronic pain clinical trials: IMMPACT recommendations","volume":"149","author":"Dworkin","year":"2010","journal-title":"Pain"},{"issue":"1","key":"2021060807584180400_pnaa416-B24","doi-asserted-by":"crossref","first-page":"e000146","DOI":"10.1136\/rmdopen-2015-000146","article-title":"Real-life assessment of the validity of patient global impression of change in fibromyalgia","volume":"1","author":"Rampakakis","year":"2015","journal-title":"RMD Open"},{"key":"2021060807584180400_pnaa416-B25","first-page":"63","article-title":"Hyperbaric oxygen treatment of fibromyalgia: A prospective observational clinical study","volume":"37(suppl 116","author":"Atzeni","year":"2019","journal-title":"Clin Exp Rheumatol"},{"key":"2021060807584180400_pnaa416-B26","first-page":"81","article-title":"T helper 1 response is correlated with widespread pain, fatigue, sleeping disorders and the quality of life in patients with fibromyalgia and is modulated by hyperbaric oxygen therapy","volume":"37(suppl 116","author":"Guggino","year":"2019","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"2021060807584180400_pnaa416-B27","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/art.1780380104","article-title":"The prevalence and characteristics of fibromyalgia in the general population","volume":"38","author":"Wolfe","year":"1995","journal-title":"Arthritis Rheum"},{"issue":"1","key":"2021060807584180400_pnaa416-B28","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/acr.22626","article-title":"Understanding the association of fatigue with other symptoms of fibromyalgia: Development of a cluster model","volume":"68","author":"Lukkahatai","year":"2016","journal-title":"Arthritis Care Res"},{"issue":"1","key":"2021060807584180400_pnaa416-B29","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12894-019-0545-6","article-title":"Clinical and morphological effects of hyperbaric oxygen therapy in patients with interstitial cystitis associated with fibromyalgia","volume":"19","author":"Bosco","year":"2019","journal-title":"BMC Urol"}],"container-title":["Pain Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/painmedicine\/article-pdf\/22\/6\/1324\/38490851\/pnaa416.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/painmedicine\/article-pdf\/22\/6\/1324\/38490851\/pnaa416.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,8]],"date-time":"2021-06-08T04:39:03Z","timestamp":1623127143000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/painmedicine\/article\/22\/6\/1324\/6140166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,16]]},"references-count":29,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,2,16]]},"published-print":{"date-parts":[[2021,6,4]]}},"URL":"https:\/\/doi.org\/10.1093\/pm\/pnaa416","relation":{},"ISSN":["1526-2375","1526-4637"],"issn-type":[{"value":"1526-2375","type":"print"},{"value":"1526-4637","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,6,1]]},"published":{"date-parts":[[2021,2,16]]}}}